NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and QuantuMDx today announced a collaboration to develop point-of-care diagnostic tests specifically for the Asian population.

Under the terms of the deal, QuantuMDx's Singapore-based subsidiary QMDx Asia and GIS will develop the tests using QuantuMDx's Q-POC handheld point-of-care device. The Newcastle, UK-based firm will commercialize the tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.